Gladstone Capital Corporation Reports Increase in Quarterly

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Gladstone Capital Corporation Reports Increase in Quarterly Net Investment Income of 13.3%

MCLEAN, Va., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Gladstone Capital Corporation (NASDAQ: GLAD ) (the "Company") today announced earnings for its fourth quarter and fiscal year ended September 30, 2015. Please read the Company's Annual Report on Form 10-K filed today with the U.S. Securities and Exchange Commission (the "SEC"), which can be retrieved from the SEC's website at www.sec.gov , or from the Company's website at www.GladstoneCapital.com .

Fourth Fiscal Quarter Over Quarter Highlights:

  • Net investment income increased 13.3% to $5.48 million or $0.26 per common share
  • Net investment growth of $28.5 million
  • Maintained average yield on earning investments at 11.3%
  • Effective 7/1/15, reduced the Base Management Fee payable to its adviser by 12.5% to 1.75% per year
  • Restructured or exited two non-earning assets
  • Net asset value declined $9.2 million to $191.4 million or $9.06 per share as a result of estimated taxes on a large equity gain which closed subsequent to quarter end
  • Paid monthly dividends totaling $0.21 

President, Robert L. Marcotte commented, "We are very pleased to report strong earnings for the fourth fiscal quarter of 2015. This quarter represents the culmination of several initiatives on the year: to grow our proprietary lower middle market investments; maintain investment yields while shifting to more senior secured assets; and lower our costs to enhance our returns to shareholders. For fiscal year 2015, we grew our investments by 30% as our new originations continued to average almost $30 million per quarter.  Our net interest margin widened over the year with the mid-year reduction in our average funding cost. Based on these trends, the reduced management fee and the lift associated with the reinvestment of a large capital gain realized after the end of the quarter, we have ample capacity to grow our earnings and potential shareholder distributions in the future."

Summary Information (dollars in thousands, except per share data) (unaudited) :

  For the Quarter Ended: September 30, 2015 June 30, 2015   Change % Change
         
Total investment income $ 10,174 $9,935 $239 2.4%
Total expenses, net of credits (4,694 ) (5,099) 405 7.9
Net investment income 5,480 4,836 644 13.3
Net investment income per common share 0.26 0.23 0.03 13.3
Cash distribution per common share 0.21 0.21 — —
Net realized loss (19,661 ) (1,075) (18,586) NM
Net unrealized appreciation (depreciation) 9,485 (454) 9,939 NM
Net (decrease) increase in net assets resulting from operations (4,696 ) 3,307 (8,003) NM
Weighted average yield on interest-bearing investments (A) 11.3 % 11.2% 0.01% 0.1
Total invested $ 40,333 $1,325 $39,008 NM
Total repayments and proceeds 11,837 15,807 (3,970) (25.1)
         
         
As of: September 30, 2015 June 30, 2015 Change % Change
Total investments, at fair value $ 365,891 $347,216 $18,675 5.4%
Fair value, as a percent of cost 89.2 % 86.6% 2.6% 3.0
Net asset value per common share $ 9.06 $9.49 $(0.43) (4.5)

Fourth Quarter Portfolio Review:

On the quarter the Company closed four new proprietary investments representing $37.0 million and exited one syndicated loan and one non-accrual investment for total proceeds of $8.2 million. 

New originations included:

  • $7.2 million secured second lien debt and equity co-investment in Mikawaya, a producer of specialty frozen desserts;
  • $13.0 million secured first lien debt in TWS Acquisition Corporation, a post-secondary skilled trade school;
  • $8.3 million secured first lien debt and equity co-investment in Triple H Food Processors, Inc., a co-packer of branded and private label liquid and related food products; and
  • $8.5 million secured first lien debt and equity co-investment in Flight Fit N Fun, LLC, a trampoline park operator.

Fourth Quarter 2015 Results and Distributions :

Net Investment Income for the quarter ending September 30, 2015 was $5.5 million, or $0.26 per share, compared to $4.8 million, or $0.23 per share for the quarter ending June 30, 2015. Total investment income increased by 2.4% quarter over quarter primarily due to an increase in the weighted average interest bearing investment portfolio. Total expenses declined by 7.9%, quarter over quarter, primarily due to the reduced base management fee effective July 1, 2015 and an increase of $0.4 million in base management fee credits, when compared to the quarter ended June 30, 2015.

Net (Decrease) Increase in Net Assets Resulting from Operations for the quarter ended September 30 and June 30, 2015 was $(4.7) million, or $(0.22) per share, compared to $3.3 million, or $0.16 per share, respectively. The quarter over quarter decrease is primarily due to the estimated tax liability associated with the expected sale of one of our portfolio companies that closed after the end of the quarter. 

The Company paid monthly distributions for each of July, August and September 2015 to common stockholders ($0.07 per common share) and to preferred stockholders ($0.140625 per share of the Company's 6.75% Series 2021 Term Preferred Stock). 

  For the Year Ended: September 30, 2015 September 30, 2014   Change % Change
         
Total investment income $ 38,058 $36,585 $1,473 4.0%
Total expenses, net of credits (20,358 ) (18,217) (2,141) (11.8)
Net investment income 17,700 18,368 (668) (3.6)
Net investment income per common share 0.84 0.87 (0.03) (3.4)
Cash distribution per common share 0.84 0.84 — —
Total net realized loss (34,176 ) (13,410) (22,063) NM
Total net unrealized appreciation 24,960 6,275 18,685 NM
Net increase in net assets resulting from operations 8,484 11,233 (2,749) (24.5)
Weighted average yield on interest-bearing investments (A) 11.3 % 11.6% (0.03)% (0.3)
Total invested $ 134,097 $102,020 $32,077 31.4
Total repayments and proceeds 40,273 72,561 (32,288) (44.5)
         
As of: September 30, 2015 September 30, 2014 Change % Change
Total investments, at fair value $ 365,891 $281,286 $84,605 30.1%
Fair value as a percent of cost 89.2 % 80.5% 8.7% 10.8
Net asset value per common share $ 9.06 $9.51 $(0.45) (4.7)
NM =Not Meaningful
(A)  Excludes reserves on interest receivables and non-accrual loans.

Fiscal Year Ended 2015 Results and Distributions:

Net Investment Income for the years ended September 30, 2015 and 2014, was $17.7 million, or $0.84 per share, and $18.4 million, or $0.87 per share, respectively. Total investment income increased by 4.0% year over year primarily due to an increase in the weighted average interest bearing investment portfolio during the year ended September 30, 2015. Total expenses increased 11.8%, year over year, primarily due to an increase in interest expense on borrowings due to a higher outstanding balance on our credit facility during the year.

Net Increase in Net Assets Resulting from Operations for the years ended September 30, 2015 and 2014, was $8.5 million, or $0.40 per share, compared to $11.2 million, or $0.53 per share, respectively. The year over year decrease is primarily due to the aforementioned net investment income results and also the estimated tax liability associated with the expected sale of one of our portfolio companies that closed after quarter end. 

The Company paid monthly distributions for each of the twelve months ended September 30, 2015 and 2014 to common stockholders ($0.84 per common share per year) and to preferred stockholders (approximately $1.69 per share of the Company's 6.75% Series 2021 Term Preferred Stock per year). 

Subsequent Events:  Subsequent to September 30, 2015, the following significant events occurred:

  • Portfolio Activity: Received $55.6 million in repayments and net proceeds from existing portfolio companies, including $11.4 million from the sale of two syndicated loan investments, $1.5 million from the exit of a non-accrual investment and proceeds of $35.3 million from the early payoff/exit of two proprietary investments including a realized gain of approximately $16.6 million on an equity investment. 
  • Common Stock Offering: Completed a public offering of 2.3 million shares of our common stock, including the overallotment. Gross proceeds totaled $19.7 million and net proceeds, after underwriting discounts and offering costs were approximately $18.4 million. 
  • Distributions Declared:  Declared the following monthly cash distributions to stockholders on October 14, 2015:
Record Date Payment Date Distribution per Common Share Distribution per Series 2021 Term Preferred Share
October 26 November 4 $0.07 $0.140625
November 17 November 30 0.07 0.140625
December 18 December 31 0.07 0.140625
Total for the Quarter   $0.21 $ 0.421875  

Conference Call for Stockholders: The Company will hold its earnings release conference call on Tuesday, November 24, 2015, at 8:30 a.m. EST. Please call (855) 465-0177 to enter the conference. An operator will monitor the call and set a queue for any questions. A replay of the conference call will be available through December 24, 2015. To hear the replay, please dial (855) 859-2056 and use conference number 61294306. The replay of the conference call will be available beginning approximately one hour after the call concludes. The live audio broadcast of the Company's quarterly conference call will also be available online at www.GladstoneCapital.com . The event will be archived and available for replay on the Company's website through January 24, 2016.

Forward-looking Statements:  The statements in this press release regarding the Company's capacity for growth and future distributions are "forward-looking statements." These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on the Company's current plans that are believed to be reasonable as of the date of this press release, a number of factors could cause actual results and conditions to differ materially from these forward-looking statements, including those factors described from time to time in Gladstone Capital's filings with the Securities and Exchange Commission. Gladstone Capital undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or otherwise, except as required by law.

About Gladstone Capital Corporation: Gladstone Capital Corporation is a publicly traded business development company that invests in debt and equity securities, consisting primarily of secured first and second lien term loans to small and medium sized businesses in the United States. Including distributions through today, the Company has paid 153 consecutive monthly or quarterly cash distributions on its common stock, which over the past five years total approximately $88.3 million, or $4.20 per share. Information on the business activities of all the Gladstone funds can be found at www.GladstoneCompanies.com . 

To obtain a paper copy of the Company's most recent Form 10-K, please contact the Company at 1521 Westbranch Drive, Suite 100, McLean, VA 22102, ATTN: Investor Relations. The financial information above is not comprehensive and is without notes, so readers should obtain and carefully review the Company's Form 10-K for the quarter ended September 30, 2015, including the notes to the consolidated financial statements contained therein.

Investor Relations Inquiries: Please visit www.gladstone.com or +1-703-287-5893.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 23

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 11

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 14

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 13

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 28

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 21

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 21

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 19

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 20

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 33

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Groundbreaking for New Community by Century Communities

Updated Category News Views 191

Century Communities Breaks Ground on New Development Century Communities, Inc. (NYSE: CCS) has recently made headlines with the groundbreaking of its newest venture: a magnificent 318-acre community named Mirabella. This family-friendly location promises to provide over 1,000 new homes designed for affordability and comfort. Situated within the bustling west metro area of...

Continue Reading
Perseus Group Enhances Manufacturing Software with OptiVision

Updated Category News Views 105

Perseus Group Strengthens Its Position in the Industry Perseus Group, a dynamic operating group within Constellation Software Inc., has taken a significant step in enhancing its offerings in the pulp and paper sector. They recently announced the completion of an exciting acquisition that will support their growth strategy. The group has secured the exclusive global...

Continue Reading
Embrace Pet Insurance Breaks Records in Volunteerism and Giving

Updated Category News Views 267

Embrace Pet Insurance Partners in Charity and Volunteerism Despite facing economic hurdles, charitable contributions across the nation showed remarkable resilience, highlighting the generosity of individuals and businesses alike. Recent reports reveal that charitable donations in the U.S. hit staggering heights, exceeding $557 billion in the last reporting year. Embrace...

Continue Reading
Biocon Biologics Achieves Key FDA Approval for Jobevne™ in Oncology

Updated Category News Views 173

Biocon Biologics Secures FDA Approval for Jobevne™ Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for Jobevne™ (bevacizumab-nwgd). This biosimilar to the well-known Avastin (bevacizumab) is designed for intravenous use and aims to treat various types of cancer....

Continue Reading